Stephen Paul Hack
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver physiology and pathology 3
-
- Neuroscience and Neuropharmacology Research 6
- Neuropeptides and Animal Physiology 4
- Neurotransmitter Receptor Influence on Behavior 2
- Co-authors
- MacDonald J. Christie (6 shared papers)Nicholas W. Choong (2 shared papers)Caroline Dutriaux (2 shared papers)Michele Maio (2 shared papers)Gabriella Liszkay (2 shared papers)Paolo A. Ascierto (2 shared papers)Daniil Stroyakovskiy (1 shared paper)Ilsung Chang (1 shared paper)
- Journals
- Annals of Oncology (3 papers)The Lancet Oncology (2 papers)Journal of Neuroscience (2 papers)Journal of Neurophysiology (2 papers)The Lancet (2 papers)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Stephen Paul Hack
32 papers receiving 4.0k citations
Stephen Paul Hack's Hit Papers
Peers
Comparison fields: 5 of 101
- Hepatology 835
- Oncology 1.6k
- Molecular Biology 1.7k
- Cellular and Molecular Neuroscience 408
- Cancer Research 299
Countries citing papers authored by Stephen Paul Hack
This map shows the geographic impact of Stephen Paul Hack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Paul Hack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Paul Hack more than expected).
Fields of papers citing papers by Stephen Paul Hack
This network shows the impact of papers produced by Stephen Paul Hack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Paul Hack. The network helps show where Stephen Paul Hack may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Paul Hack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma Hit paper breakdown → | 2014 | 1697 |
| 2 | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study Hit paper breakdown → | 2020 | 469 |
| 3 | Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2023 | 362 |
| 4 | 2016 | 254 | |
| 5 | 2020 | 212 | |
| 6 | 2020 | 174 | |
| 7 | 1999 | 81 | |
| 8 | 2003 | 79 | |
| 9 | 2019 | 72 | |
| 10 | 2005 | 71 | |
| 11 | 2005 | 66 | |
| 12 | 2014 | 61 | |
| 13 | 2004 | 61 | |
| 14 | 1993 | 60 | |
| 15 | 2004 | 57 | |
| 16 | 2017 | 50 | |
| 17 | Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study Hit paper breakdown → | 2025 | 47 |
| 18 | 2003 | 42 | |
| 19 | 2021 | 38 | |
| 20 | 1986 | 34 |
About Stephen Paul Hack
Stephen Paul Hack is a scholar working on Hepatology, Cellular and Molecular Neuroscience, Oncology, Surgery and Physiology, having authored 33 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Neuropeptides and Animal Physiology (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Liver physiology and pathology (3 papers), Melanoma and MAPK Pathways (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Hepatology (835 citations), Oncology (1.6k citations), Molecular Biology (1.7k citations), Cellular and Molecular Neuroscience (408 citations) and Cancer Research (299 citations). Stephen Paul Hack has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include MacDonald J. Christie, Nicholas W. Choong, Caroline Dutriaux, Michele Maio, Gabriella Liszkay, Paolo A. Ascierto, Daniil Stroyakovskiy, Ilsung Chang, Claus Garbe and James Larkin. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, Journal of Neuroscience, Journal of Neurophysiology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.